AOTI Inc Sustainability Reports
AOTI, Inc. develops and commercializes advanced tissue-healing technologies for patients with chronic conditions. The company's primary focus is its proprietary Topical Wound Oxygen (TWO2) homecare therapy, which is used to treat severe wounds such as diabetic foot ulcers and venous leg ulcers.
Sector: Manufacturing
Country: United States
Exchange: London Stock Exchange (AIM)
LEI: 213800ZGCNDSTWIRK687
FIGI: BBG00201F4V3
1 reports from 2025 to 2025
